Jnj sotck.

25 Okt 2023 ... We estimate Johnson & Johnson's Valuation to be $159 per share, reflecting only a 5% upside from its current levels of $151. Our forecast is ...The latest Johnson & Johnson stock prices, stock quotes, news, and JNJ history to help you invest and trade smarter.JNJ is currently trading at an EV/NTM Revenue of 4.43x, in line with its 3Y mean of 4.62x. Analysts also rate JNJ stock as fair value now, given its capability and reasonable valuation.Best Free Stock Trading Platforms. Best Robo-Advisors. Index Funds. ... Health-care conglomerate Johnson & Johnson announced plans Friday to split its consumer products business from its ...

The exchange offer provides a boon to J&J ( JNJ) shareholders as they would get Kenvue ( KVUE) stock at around a 7% discount. These shareholders would get $107.53 of Kenvue ( KVUE) common stock ...The latest closing stock price for Johnson & Johnson as of November 29, 2023 is 152.11. The all-time high Johnson & Johnson stock closing price was 177.11 on April 25, 2022. The Johnson & Johnson 52-week high stock price is 181.04, which …0.06%. £157.78B. Medtronic PLC. 0.77%. $105.07B. JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Jun 8, 2023 · JNJ: Earnings, Valuation, Dividend, Free Cash Flow Forecasts BofA Global Research Specifically, if we assume $10.70 of NTM EPS and apply a 16 multiple (just under its 5-year average), then shares ... JNJ stock has seen little change, moving slightly from levels of $155 in early January 2021 to around $150 now, vs. an increase of about 10% for the S&P 500 over this roughly 3-year period.

Feb 27, 2023 · Johnson & Johnson in Focus Johnson & Johnson (JNJ) is headquartered in New Brunswick, and is in the Medical sector. The stock has seen a price change of -11.71% since the start of the year. Jun 8, 2023 · JNJ: Earnings, Valuation, Dividend, Free Cash Flow Forecasts BofA Global Research Specifically, if we assume $10.70 of NTM EPS and apply a 16 multiple (just under its 5-year average), then shares ... Johnson & Johnson historical stock charts and prices, analyst ratings, financials, and today’s real-time JNJ stock price.Analyst Forecast. According to 15 analysts, the average rating for JNJ stock is "Buy." The 12-month stock price forecast is $168.0, which is an increase of 10.45% from the latest price.News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive $158.38 +3.72 (2.41%) View Full Chart As of Dec 1, 2023 4:00pm...

Nov 20, 2023 · Get step-by-step guidance on investing in Johnson & Johnson stock and learn the ins and outs of this healthcare company. Johnson & Johnson (JNJ 2.4%) is an iconic global healthcare company. It was ...

Find the latest Adobe Inc. (ADBE) stock quote, history, news and other vital information to help you with your stock trading and investing.

When Johnson & Johnson (JNJ 0.32%) ... 10 stocks we like better than Johnson & Johnson When our award-winning analyst team has a stock tip, it can pay to listen. After all, ...Jul 20, 2023 · Johnson & Johnson said its shareholders will soon be able to swap their shares for stock of Kenvue, which spun out as an independent consumer health company just two months ago. J&J owns nearly 90 ... Johnson & Johnson (JNJ) stock: Why and when will it split. One company would focus on consumer health products and the other on pharmaceuticals and medical devices.The second key opportunity stems from Johnson & Johnson’s valuation multiple compared to its peers. The stock now trades at 18x its projected 2020 adjusted earnings per share of about $8.01. In ...For the current quarter, Johnson & Johnson is expected to post earnings of $2.51 per share, indicating a change of -6% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.3% ...Oct 17, 2023 · Here’s what J&J reported for the third quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG, formerly known as Refinitiv: Earnings per share: $2.66 ... In depth view into JNJ (Johnson & Johnson) stock including the latest price, news, dividend history, earnings information and financials.

The exchange offer provides a boon to J&J ( JNJ) shareholders as they would get Kenvue ( KVUE) stock at around a 7% discount. These shareholders would get $107.53 of Kenvue ( KVUE) common stock ...A high-level overview of Johnson & Johnson (JNJ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.With an average target price of $178.79, analysts give JNJ stock implied upside of about 10% in the next 12 months or so. Add in the dividend yield, and the implied total return comes to roughly 13%.Beta is a measure of risk commonly used to compare the volatility of stocks, mutual funds, or ETFs to that of the overall market. The S&P 500 Index is the base for calculating beta with a value of ...For clarity, the terminal value of JNJ's cash flows ($182 billion) is not shown in the graph, but even if it is excluded, artificially increasing the impact of litigation on valuation, JNJ stock ...Dec 1, 2023 · Get the latest Johnson & Johnson (JNJ) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.

Find the latest The Procter & Gamble Company (PG) stock quote, history, news and other vital information to help you with your stock trading and investing.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Johnson & Johnson (JNJ 0.72%) stock had a bit of a hangover Wednesday. Following the estimates-beating third-quarter results that the company posted Tuesday, its share price fell by more than 2%.Get the latest Johnson & Johnson (JNJ) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Developing products for healthier people and planet. Innovating to create formulations that have the power to change the world while protecting the planet. Everyday care is a powerful catalyst in making you feel better, inside and out. Learn about the iconic brands, products, people, and history that make up Kenvue.Nov 12 (Reuters) - Johnson & Johnson (JNJ.N) plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices in the biggest ...Johnson & Johnson (JNJ) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. 🚀 Enjoy a 7-Day Free Trial Thru Dec 07, 2023! Sign UpKey Points. Johnson & Johnson on Monday said it plans to reduce its stake in Kenvue by at least 80% via an exchange offer. The offer will allow J&J shareholders to swap all or a portion of their ...Find the latest Johnson & Johnson (JNJ) stock forecast, 12-month price target, predictions and analyst recommendations.JNJ: New York Stock Exchange: 0.650% Notes Due May 2024: JNJ24C: New York Stock Exchange: 5.50% Notes Due November 2024: JNJ24BP: New York ... The aggregate market value of the Common Stock held by non-affiliates computed by reference to the price at which the Common Stock was last sold as of the last business day of the …Nov 29, 2023 · Get Johnson & Johnson (JNJ.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

Current and historical p/e ratio for Johnson & Johnson (JNJ) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.

Get today's JNJ stock price and latest Johnson & Johnson stock news as well as JNJ real-time stock quotes, technical analysis, full financials and more.

NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib). Johnson & Johnson MedTech acquired Laminar for an upfront ... J&J stock price quote (NYSE: JNJ), historical charts, related news, stock analyst insights and more to help you make the right investing decisions.J&J (JNJ) completed the separation of Kenvue (KVUE), making its consumer health spinoff a fully independent business, the companies said Wednesday. Read more here.Dec 2, 2023 · Get Johnson & Johnson (JNJ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments ... One Johnson & Johnson Plaza NEW BRUNSWICK, NJ ... JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Get the latest Johnson & Johnson (JNJ) stock news and headlines to help you in your trading and investing decisions.Get step-by-step guidance on investing in Johnson & Johnson stock and learn the ins and outs of this healthcare company. Johnson & Johnson (JNJ 2.4%) is an iconic global healthcare company. It was ...JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Johnson & Johnson (JNJ) stock: Why and when will it split. One company would focus on consumer health products and the other on pharmaceuticals and medical devices.Johnson & Johnson (NYSE: JNJ) has a price-to-earnings ratio of 30.23x that is above its average ratio. Additionally, the 36-month beta value for JNJ is 0.57. There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 2 rating it as “overweight,” 13 rating it as “hold,” and 0 rating it […]Get step-by-step guidance on investing in Johnson & Johnson stock and learn the ins and outs of this healthcare company. Johnson & Johnson (JNJ 2.4%) is an iconic global healthcare company. It was ...Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Kenvue intends to raise an estimated $5 billion in gross proceeds from an IPO of its common stock. The company is beginning the separation process from parent firm Johnson & Johnson. All the ...Find the latest Enbridge Inc. (ENB) stock quote, history, news and other vital information to help you with your stock trading and investing.Johnson & Johnson Stock Price, News & Analysis (NYSE:JNJ) $154.56 +2.45 (+1.61%) (As of 12:45 PM ET) Compare Today's Range $151.92 $154.58 50-Day …Instagram:https://instagram. books by charlie mungerestate weed and feedmain 401k companiesfidelity crypto ira Jul 20, 2023 · JNJ stock analysts expected profit of $2.62 a share and $24.63 billion in sales. Pharmaceutical sales delivered most of the upside, Third Bridge's Brown said. Overall sales rose 3.1% to $13.73 ... A high-level overview of Johnson & Johnson (JNJ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. american bond fund of america ahow to watch furman vs south carolina Beta is a measure of risk commonly used to compare the volatility of stocks, mutual funds, or ETFs to that of the overall market. The S&P 500 Index is the base for calculating beta with a value of ...Make a stock purchase. Access Issuer Online. W e are a global leader in transfer agency, employee equity plans, mortgage servicing, proxy solicitation, stakeholder communicatio ns, and other diversified financial and governance services. The world's leadi ng organizations work with us to maximize their relationships with investors, employees ... nrg ceo Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing.JNJ stock has seen little change, moving slightly from levels of $155 in early January 2021 to around $150 now, vs. an increase of about 10% for the S&P 500 over this roughly 3-year period.Nov 30, 2023 · Contact Investor Relations. Questions? Please contact us: 1-800-950-5089 [email protected].